Skip to main content
. 2020 Aug 22;15:96–103. doi: 10.1016/j.ejcsup.2019.11.002

Fig. 2.

Fig. 2

Ovarian cancer subtypes can be matched with different targeted therapies based on the molecular study findings, usually in clinical trials.